Malignant Neoplasm of Breast: Clinical Trials

3 trials for Malignant Neoplasm of Breast, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Malignant Neoplasm of Breast: new trials by email Literature Review of Malignant Neoplasm of Breast trials Research Report on Malignant Neoplasm of Breast

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Pembrolizumab, Clostridium Novyi-NT, Doxycycline - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs
Phase 1CompletedM.D. Anderson Cancer Center182018-07-102026-11-03
Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer
DS-8201a - Malignant Neoplasm of Breast
Phase 1CompletedDaiichi Sankyo Co., Ltd.512017-12-262022-04-12
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors
Alisertib, Pazopanib - Malignant Neoplasm of Breast, CNS Malignancy
Phase 1CompletedUniversity of Illinois at Chicago282013-08-142019-07-22

Narrower conditions

Breast Neoplasms (3)  ·  Central Nervous System Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Urologic Neoplasms (1)

Broader conditions

Breast Diseases (3)  ·  Neoplasms by Site (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Neoplasms (2)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Nervous System Diseases (1)

Interventions

Doxycycline (1)  ·  MLN 8237 (1)  ·  pazopanib (1)  ·  pembrolizumab (1)  ·  trastuzumab deruxtecan (1)

Sponsors

Daiichi Sankyo Co., Ltd. (1)  ·  M.D. Anderson Cancer Center (1)  ·  University of Illinois at Chicago (1)

Countries

United States (2)  ·  Japan (1)

Top investigators

Arkadiusz Z. Dudek, M.D. (1)  ·  Sarina Piha-Paul, MD (1)  ·  Sarina Piha-Paul, MD, PHD (1)

Results publications

PMID 30973373, PMID 36164935